NEIAA Collection: Available Now in the BSR Journals
A dedicated collection showcasing the latest research from NEIAA is
now available through the BSR Journals.. Explore the most up to date NEIAA research in this unique collection, which highlights the latest findings informed by national clinical audit data on the referral, assessment, treatment, and outcomes of adults living with inflammatory arthritis in England and Wales.
Please note that while
Rheumatology Advances in Practice is open access, access to
Rheumatology is subscription based. The good news is that BSR members are entitled to free access to
Rheumatology - please contact
membership@rheumatology.org.uk if you would like more information on membership.
Publication of the NEIAA Annual Report 2024
The audit team is excited to announce the publication of the sixth annual NEIAA State of the Nation Summary Report.
This year's report includes six key messages and five national recommendations. Each recommendation is supported by evidence in the report and aims to improve the quality of care for people living with inflammatory arthritis in England and Wales. In addition, the report provides the first-ever national benchmarking of waiting times for patients with some rare autoimmune rheumatic diseases.
You can read the report itself here:
National Early Inflammatory Arthritis Audit (NEIAA) State of the Nation Summary Report 2024. Thank you to all staff to submitted data and contributed to the audit. Your hard work and dedication to improving rheumatology care is greatly appreciated.
Celebrating Audit Participation: Introducing NEIAA Certificates of Achievement
We're delighted to announce that an editable certificate is now available for clinical leads to award to colleagues for their contributions to the National Early Inflammatory Arthritis Audit (NEIAA). The certificate can be downloaded by Clinical Leads (under the User Admin tab) and the accompanying certificate guidance can also be found on the Resources page. Clinical Leads are welcome to directly award these to colleagues who have recruited at least five eligible patients to the audit. This includes rheumatology trainees, healthcare professionals and admin staff.
BSR E-Learning Spotlight on NEIAA
The British Society for Rheumatology has carefully curated a range of educational resources exploring the National Early Inflammatory Arthritis Audit in its e-learning spotlight for February 2024. Create a free BSR account today, and access the e-learning here:
https://www.rheumatologylearning.com/
New Resource: Standard Responses to Referrals and Requests for Specialist Advice
BSR has developed standard responses to referrals and requests for specialist advice with input from clinicians and specialist across the UK. We hope these documents will help your department to more efficiently respond to common advice requests from referrers. You can find out more on our website, where you will also find our Referral Criteria Guidance and Best Practice resources:
https://www.rheumatology.org.uk/improving-care/specialist-advice-referral-and-triage.
National Data Opt-out (NDO) Update
The National Early Inflammatory Arthritis Audit (NEIAA) is no longer exempt from the National Data Opt-out (NDO), as of 7 July 2023. Clinical teams must now check each patient's NDO status before submitting any confidential patient data into the audit. Further information can be found here.
Resources have been compiled by NHS Digital to support with NDO compliance, these can be found here.
Patient Eligibility From 1 April 23
Patient eligibility within the audit has changed from 1 April 23. Patients should now only be entered into the audit when they have a confirmed diagnosis of EIA (Rheumatoid arthritis, Psoriatic arthritis, Axial spondyloarthropathy, Undifferentiated inflammatory arthritis). Year 4 data suggests this will result in a 65% reduction in data burden. In addition to this, patients with confirmed diagnosis of CTD and Systemic Vasculitis, a full list of diagnosis are listed here
CTD:
Systemic lupus erythematosus
Primary Sjogren’s syndrome
Systemic sclerosis
Idiopathic inflammatory myopathy
Undifferentiated/other connect tissue disease or overlap syndrome
Systemic Vasculitis:
Giant cell arteritis
Large vessel vasculitis (not giant cell arteritis)
Anti-neutrophil cytoplasmic antibody-associated vasculitis
Small/medium vessel vasculitis (anti-neutrophil cytoplasmic antibody-negative)
Behçet’s syndrome
There is more information about the changes to data collection here: Changes to The National Early Inflammatory Arthritis Audit (rheumatology.org.uk).
If you have any questions about these changes, please contact the team at audit@rheumatology.org.uk.
